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Abstract
Background: Microglia and its polarization play critical roles in intracerebral hemorrhage-induced secondary brain
injury. Programmed death protein 1/programmed death-ligand 1 has been reported to regulate neuroimmune cell
functions. Signal transducers and activators of transcription 1 participate in microglia polarization, and programmed
death protein 1/programmed death-ligand 1 could regulate the activation of signal transducers and activators of
transcription 1. We herein show the critical role of programmed death protein 1/programmed death-ligand 1 in the
polarization of microglia during intracerebral hemorrhage-induced secondary brain injury in rat models.
Methods: An autologous blood intracerebral hemorrhage model was established in Sprague Dawley rats (weighing
250–300 g), and primary cultured microglia was exposed to oxyhemoglobin to mimic intracerebral hemorrhage in
vitro. Specific siRNAs and pDNA for programmed death protein 1 and programmed death-ligand 1 were exploited
both in vivo and in vitro.
Results: In the brain tissue around hematoma, the protein levels of programmed death protein 1 and programmed
death-ligand 1 and the interaction between them, as well as the phosphorylation of signal transducers and
activators of transcription 1, were higher than that of the sham group and collectively peaked at 24 h after
intracerebral hemorrhage. Overexpression of programmed death protein 1 and programmed death-ligand 1
ameliorated intracerebral hemorrhage-induced secondary brain injury, including brain cell death, neuronal
degeneration, and inflammation, while their knockdown induced an opposite effect. In addition, overexpression
of programmed death protein 1 and programmed death-ligand 1 selectively promoted microglia polarization to
anti-inflammation phenotype after intracerebral hemorrhage and inhibited the phosphorylation of signal
transducers and activators of transcription 1, suggesting that intracerebral hemorrhage-induced increases in
programmed death protein 1 and programmed death-ligand 1 maybe a self-help.
Conclusions: Enhancing the expressions of programmed death protein 1 and programmed death-ligand 1 may induce
a selective modulation of microglia polarization to anti-inflammation phenotype for intracerebral hemorrhage treatment.
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Background
Intracerebral hemorrhage (ICH) accounts for ~15% of
stroke cases in developed countries and ~50% or more in
developing countries, especially in regions of Asia with
high incidence of hypertension [1–3]. And ICH severely
reduces the quality of life of patients, with a 5-year sur-
vival rate of ~30% [4, 5]. Beside blood clot-induced pri-
mary injury in the early phase [6], a series of chemical and
immune responses known as secondary brain injury (SBI)
seriously affect the prognosis of patients and is likely to be
subjected to intervention [7–9].
Recent reports have shown that microglia/macrophages
are the main regulatory cells in the immune defense re-
sponse of the central nervous system (CNS) that affect
subsequent inflammatory processes [10, 11]. After brain
injury, a large number of microglia and macrophages
around the hematoma rapidly respond and release effector
molecules [12, 13]. Numerous recent studies have shown
that in response to brain injury, different phenotypes of
microglia/macrophages are observed and play various
roles based on signals released in the microenviron-
ment [11, 13]. Two main phenotypes of microglia/mac-
rophages are pro-inflammatory phenotype and anti-
inflammatory phenotype. Pro-inflammatory phenotype
promotes inflammation and kills microorganisms, while
anti-inflammatory inhibits inflammation and is involved
in tissue repair and reconstruction [13]. Microglia acti-
vation and polarization during experimental intracere-
bral hemorrhage has been reported [14, 15].
Programmed death-1 (PD-1; also known as CD279 or
PDCD1), which is a transmembrane glycoprotein of the
CD28/cytotoxic T lymphocytes associated antigen-4
(CTLA-4) immunoglobulin superfamily, was first discov-
ered in 1992 [16]. Its ligands, programmed death-ligand
1 (PD-L1) (B7-H1) and PD-L2 (B7-CD), are type I trans-
membrane proteins of the B7 family. PD-1 inhibits
phosphatidylinositol-3-kinase (PI3K) and protein kinase
B (Akt) activities [17]. The PI3K-Akt signaling pathway
is involved in mediating phosphorylation of signal trans-
ducers and activators of transcription 1 (STAT1) [18],
which has been reported to promote pro-inflammatory
phenotype polarization of microglia [19]. PD-L2, another
ligand of PD-1, was reported to have a threefold higher
affinity for PD-1 compared with PD-L1 [20]. However,
studies of the PD-1/PD-L2 signaling pathway have been
rarely reported. Numerous studies have shown that PD-
1/PD-Ls play important roles in mediating CNS disor-
ders such as ischemic stroke [21], multiple sclerosis [22],
and Alzheimer’s disease [23].
In conclusion, accumulating researches suggested a
therapeutic potential of PD-1/PD-Ls in ICH-induced SBI
via regulating microglia polarization. However, until
now, no study has investigated the contribution of PD-
1/PD-Ls to microglia polarization. Therefore, the aim of
this study was to investigate the role of PD-1/PD-Ls and




Adult male Sprague Dawley rats weighing 250–300 g
were purchased from the Laboratory Animal Center,
Medical College of Soochow University, Suzhou, Jiangsu,
China. The animal experimental protocols were approved
by the Animal Care and Use Committee of Soochow
University and complied with the ARRIVE guidelines. All
animals were housed in a quiet environment maintained
at 18–22 °C with stable humidity, and animals had free ac-
cess to food and water.
ICH modeling in rats
As described by Deinsberger et al., ICH modeling in rats
was performed by injecting autologous arterial blood
into the basal ganglia [24]. Rats were anesthetized by in-
traperitoneal injection of 10% chloral hydrate (36 mg/
100 g bodyweight). After successful anesthesia, rats were
placed in the prone position, and their heads were fixed
with a stereotaxic frame (ZH-Lanxing B-type stereotaxic
frame, Anhui Zhenghua Biological Equipment Co., Ltd.
Anhui, China). The drill site of each animal was deter-
mined according to the stereotaxic atlas of the rat brain
(arterial blood injection in this experiment was unified
in the right basal ganglia) and was located 0.2 mm ros-
tral to and 3.5 mm lateral to the anterior fontanelle
(bregma). After stereotaxic positing, a cranial drill was
used to drill a ~1-mm-diameter hole through the skull
to the dura mater. A 100 μL microsyringe (Hamilton
Company, Reno, NV) was fixed to a vertical position on
the stereotaxic frame, and the needle head and dental
drill were then aligned. The position of the stereotactic
frame was fixed, and the microsyringe was removed.
The hind limbs of the rat were then repositioned to face
upward. The abdominal skin was disinfected, and a ven-
tral midline laparotomy incision of ~2–3 mm in length
was made. The caudal artery was carefully separated and
exposed under a dissecting microscope. The region was
rinsed with normal saline, and the caudal artery was
punctured with a microsyringe needle to collect 100 μL
of arterial blood without anticoagulant. After reposi-
tioning the animal in the stereotaxic frame, the micro-
syringe needle was slowly and vertically inserted through
the dental drill until it reached a depth of ~5.5 mm.
Next, 100 μL of autologous arterial blood was injected
into the basal ganglia at a rate of 20 μL/min. After the
injection, the needle was retained for 10 min to prevent
bleeding. The microsyringe needle was slowly with-
drawn, and sterilized bone wax was used to seal the hole
in the skull. After confirming that there was no
Wu et al. Journal of Neuroinflammation  (2017) 14:36 Page 2 of 13
hemorrhage, the incision and head skin were sutured, and
the tail incision was bandaged with pressure. Each animal
received a subcutaneous injection of 5 ml normal saline for
postoperative fluid replacement to prevent excessive loss of
body fluid. Heart rate, blood pressure, and real-time body
and rectal temperature were monitored for approximately
2 h, and temperature was maintained at 37.5 °C, until re-
covery from anesthesia. According to the four-level evalu-
ation of neurological symptoms described by Bederson et
al. [25], rats with neurological symptoms up to one to three
level(s) were considered successfully established ICH
models. Brain tissues were sampled 1 mm away from the
hematoma to avoid potential red blood cell contamination
for further study (Fig. 1a).
Intracerebroventricular injection of pDNA or siRNA
The drilling site of the intracerebroventricular region for
each rat was determined as described in previous studies
[26, 27]. The relevant dosage of pDNA or small interfering
RNA (siRNA) for intracerebroventricular injection was in
accordance with manufacturer instructions. The drilling
site was located 0.2 mm caudal to and 1.6 mm lateral to
the anterior fontanelle (bregma). The depth of the drilling
site was 4.5 mm.
Microglia culture
Primary microglia-enriched cultures were prepared from
the whole brains of 1-day-old pups as described previ-
ously [28]. Rats were fixed on a dissection platform and
disinfected using 75% alcohol. The skin and skull were
opened, and brain tissues were collected. Brain tissues
were washed once in PBS and isolated from the brain
stem. The meninges and blood vessels were removed,
and the brain tissues were placed in serum-free DMEM/
F12 culture medium. The tissues were cut into small
pieces and transferred to centrifuge tubes. Next, 0.125%
trypsin was added, and the brain tissue was digested in a
water bath at 37 °C for 15 min. Trypsinization was ter-
minated by adding a serum solution. After the tissue
was precipitated, the supernatant was collected, and the
remaining tissue was homogenized and trypsinized be-
fore filtering the tissue lysate. The filtered solution was
centrifuged at 1500 rpm for 5 min. The supernatant was
removed, and the cells were resuspended in complete
culture medium before cell counting. The culture
medium was changed every 2 days, and stratified cell
layers were observed ~10 days later. Cells in the upper
layer, which were mainly microglia, and a small number
of oligodendrocytes, were semi-adherent and round with
Fig. 1 Flow chart showing rat brain tissue after ICH modeling and experimental design. a Left panel: representative image of completed isolation
of rat brain tissue after cardiac perfusion. Right panel: brain section from a rat after ICH modeling. The boxed areas represent the brain regions
used for western blot analysis and immunofluorescence staining. b, c Experimental design for in vivo experiment. d Experimental design for in
vitro experiment
Wu et al. Journal of Neuroinflammation  (2017) 14:36 Page 3 of 13
good light transmission. Cells in the lower layer were
mainly astrocytes and neurons. Subsequently, culture
flasks covered with glial cells/neurons were placed on a
shaker and mixed at 180 rpm for 15 min. The culture
medium was then collected, non-adherent cells were
washed once with PBS, and the cells were centrifuged at
1500 rpm for 5 min. After removing the supernatant,
cell pellets were resuspended with complete culture
medium and incubated with 5% CO2 at 37 °C for 15–
30 min. After changing the culture medium, the adhered
cells in the culture flasks were purified microglia.
Experimental groups
To examine PD-1 and PD-Ls expression at different time
points after ICH, rats were divided into three groups: nor-
mal control group (n = 6), sham group (n = 6), and ICH
group (n = 36) (Fig. 1b). Normal control group animals
were not subjected to a procedure. Sham group animals
underwent withdrawal of tail artery blood and sphenotre-
sia via microsyringe needle puncture reaching basal gan-
glia but not blood vessels. ICH group animals were
subjected to successful ICH modeling. The ICH group
was randomly subdivided into six groups (n = 6 each) to
collect brain samples at the indicated time points: post-
ICH 6 h, post-ICH 12 h, post-ICH 24 h, post-ICH 48 h,
post-ICH 72 h, and post-ICH 7 d. Rat brain tissues in the
sham group were collected 48 h after sphenotresia.
To assess the effect of PD-1/PD-L1 on brain injury,
rats were grouped as follows 24 h after ICH modeling
(Fig. 1c). Seventy-five rats were randomly divided into
ten groups: sham group (n = 6); ICH group (n = 6); vec-
tor group (n = 6/7, number of successful ICH models/
total number of ICH models, same below); ICH + PD-1
overexpression group (n = 6/7); ICH + PD-L1 overexpres-
sion group (n = 6/9), ICH + PD-1 overexpression + PD-L1
overexpression group (n = 6/7); ICH + control siRNA
group (n = 6/7); ICH + PD-1 siRNA group (n = 6/8); ICH
+ PD-L1 siRNA group (n = 6/8); and ICH + PD-1 siRNA
+ PD-L1 siRNA (n = 6/10). pDNA or siRNA was intracer-
ebroventricularly injected into the rats 12 h before model-
ing. Animals were killed to collect brain tissue 24 h after
ICH onsets. The serum was collected for enzyme-linked
immunosorbent assay (ELISA). DNA and siRNA transfec-
tion efficiencies of each sample were verified using west-
ern blot analysis. Subsequently, effects of PD-1/PD-L1 on
SBI and microglia polarization after ICH were determined
using terminal dexynucleotidyl transferase(TdT)-mediated
dUTP nick end labeling (TUNEL) staining, Fluoro-Jade B
(FJB) staining, western blot analysis, and immunofluores-
cence staining.
To examine the effect of PD-1/PD-L1 on microglia
polarization in vitro (Fig. 1d), cultured microglia were
randomly divided into ten groups: control group,
OxyHb group, OxyHb + vector group, OxyHb + PD-1
overexpression group, OxyHb + PD-L1 overexpression
group, OxyHb + PD-1 overexpression + PD-L1 overex-
pression group, OxyHb + control siRNA group, OxyHb +
PD-1 siRNA group, OxyHb + PD-L1 siRNA group, and
OxyHb + PD-1 siRNA + PD-L1 siRNA group. pDNA or
siRNA was transfected to the cultured microglia popula-
tions, and after 24 h, the cells were fixed with 4% formal-
dehyde. pDNA and siRNA transfection efficiencies of each
sample were verified using western blot analysis, followed
by microglia polarization analysis.
pDNA and siRNA for PD-1/PD-L1 and transfection
Specific pDNA and siRNA for PD-1 and PD-L1 were ob-
tained from Guangzhou Ribo Biotechnology Co., Ltd.
(Guangzhou, China). To improve the knockdown effi-
ciency, the interference efficiency of three different siR-
NAs (shown below) was test, and the most efficient one (I
for PD-1, III for PD-L1) was used in the following study.
PD-1 siRNA sequences:
(I) Sense: 5′ CCACCUUCACCUGCAGUUU dTdT 3′
Antisense: 3′ dTdT GGUGGAAGUGGACGUC
AAA 5′
(II) Sense: 5′ CCGCUUCCAGAUCGUACAA dTdT 3′
Antisense: 3′ dTdT GGCGAAGGUCUAGCAU
GUU 5′
(III)Sense: 5′ CCUUCUGCUCAACAGGUAU dTdT 3′
Antisense: 3′ dTdT GGAAGACGAGUUGUCC
AUA 5′
PD-L1 siRNA sequences:
(I) Sense: 5′ GCAGAUUCCCAGUAGAACA dTdT 3′
Antisense: 3′ dTdT CGUCUAAGGGUCAUCU
UGU 5′
(II) Sense: 5′ GCCGAAGUGAUCUGGACAA dTdT 3′
Antisense: 3′ dTdT CGGCUUCACUAGACCU
GUU 5′
(III)Sense: 5′ GGUCAACGCAACAGCUAAU dTdT 3′
Antisense: 3′ dTdT CCAGUUGCGUUGUCGA
UUA 5′
pDNA and siRNA sequences were dissolved in RNase-
free water to a concentration of 500 pmol/10 μL and
then diluted with the same volume of transfection re-
agent. For each rat, 4 g of nucleic acid was injected
intracerebroventricularly.
TUNEL staining
Paraffin-embedded brain sections (4–6 μm thick) were in-
cubated at 70 °C for 1 h, followed by dewaxing and rehy-
drating in xylene and graded ethanol (100, 95, 90, 80, and
70%) solutions. TUNEL fluorescence staining reagents
(Roche) were used in accordance with the manufacturer’s
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instructions. Anti-quenching mounting medium was
used to seal tissue sections between glass slides and
cover slips. Brain sections were observed under a fluor-
escence microscope, and ImageJ software was used to
analyze TUNEL staining. Six microscopic fields in each
tissue section and three sections per rat were examined
and photographed in parallel for TUNEL-positive cell
counting. Microscopy was performed by an experienced
pathologist blind to the experimental condition. The
number of TUNEL-positive cells was assessed in ≥300
cells.
FJB staining
After dewaxing the paraffin-embedded brain sections
(described above), the samples were placed in the dark
at room temperature and incubated with 0.06% KMnO4
solution for 15 min. Sections were then washed three
times with PBS (5 min/wash), incubated with FJB working
solution (containing 0.1% acetic acid solvent) for 60 min.,
and washed three times with PBS (5 min/wash). Brain sec-
tions on glass slides were air-dried at room temperature in
a dark room and sealed with anti-quenching mounting
medium and cover slips. Fluorescence microscopy was
used for observation and photography. Six microscopic
fields in each tissue section and three sections per rat were
examined and photographed in parallel for FJB-positive
cell counting. Microscopy was performed by an expe-
rienced pathologist blind to the experimental condi-
tion. The number of FJB-positive cells was assessed in
≥300 cells.
Antibodies
Mouse anti-PD-1 antibody (MA5-15780), rabbit anti-PD-
L1 antibody (PA5-20343), and rabbit anti-PD-L2 antibody
(PA5-20344) were form Thermo Fisher (USA). p-STAT1
antibody (ab29045), STAT1 antibody (ab31369), rabbit
anti-CD16 antibody (ab109223), anti-iNOS antibody
(ab15323), anti-TNF alpha antibody (ab6671), anti-IL1
beta antibody (ab9722), anti-IL4 antibody (ab9811),
and anti-IL10 antibody (ab9969) were from Abcam
(Cambridge, MA, USA). Arginase 1 antibody (GTX109242)
was form GeneTex (USA). Mouse anti-CD11b antibody
(sc-516102), goat anti-CD206 antibody (sc-34577),
mouse anti-β-actin (C4) antibody (sc-47778), normal
mouse IgG (sc-2025), normal rabbit IgG (sc-2027),
and normal goat IgG (sc-3887) were from Santa Cruz
Biotechnology. Secondary antibodies for western blot
analysis, including goat anti-rabbit IgG-HRP (sc-2004),
goat anti-mouse IgG-HRP (sc-2005), and rabbit anti-goat
IgG-HRP (sc-2922) were from Santa Cruz Biotechnology.
Secondary antibodies for immunofluorescence micros-
copy, including Alexa Fluor-555 donkey anti-rabbit IgG
antibody (A31572), Alexa Fluor-488 donkey anti-rabbit
IgG antibody (A21206), Alexa Fluor-555 donkey anti-
mouse IgG antibody (A31570), Alexa Fluor-488 donkey
anti-goat IgG antibody (A11055), Alexa Fluor-488
goat anti-mouse IgG antibody (A-11001), Alexa Fluor-
555 donkey anti-goat IgG antibody (A-21432), and Alexa
Fluor-647 goat anti-rabbit IgG antibody (A32733) were
from Invitrogen.
Immunohistochemical study
The brain samples were fixed in 4% paraformaldehyde,
embedded in paraffin, cut into 4-μm sections, and exam-
ined by immunofluorescence staining. Then, the sections
were stained with primary antibodies (all diluted 1:200;
from Santa Cruz Biotechnology, Inc.) and appropriate
secondary antibodies (1:500 dilution; Santa Cruz Bio-
technology, Inc.) as described. Normal rabbit IgG was
used as a negative control for immunofluorescence assay
(data not shown). Finally, sections were observed by a
fluorescence microscope (OLYMPUS BX50/BX-FLA/
DP70; Olympus Co., Japan). For fluorescence intensity
assay, the relative fluorescence intensity was analyzed by
use of ImageJ program by subtracting background. For
positive cell counting, six microscopic fields in each tis-
sue section and three sections per rat were examined
and photographed in parallel for positive cell counting.
Microscopy was performed by an experienced patholo-
gist blind to the experimental condition. The number of
positive cells was assessed in ≥100 cells.
Western blot analysis
The brain tissue around hematoma was thoroughly
ground on ice. RIPA lysis buffer (Beyotime Biotechnol-
ogy) was used to lyse the brain tissue for 30 min. The
lysate was then transferred to a centrifuge tube and
centrifuged at 12,000 rpm for 5 min at 4 °C. The super-
natant from each sample was collected and stored at
−20 °C. Total protein extracted from each sample was
quantified using a BSA protein concentration assay kit
(Beyotime Biotechnology). Fifty micrograms of total
protein from each sample was separated using SDS-
PAGE. After transferring the protein gel to a PVDF
membrane, corresponding proteins were probed with dif-
ferent antibodies and signals were detected using an ECL
kit. ImageJ software was used to analyze optical density of
bands.
ELISA
The concentrations of IL-1β and TNF-α in serum were
determined by corresponding ELISA kits (R&D Systems
Inc., USA). These assays were performed according to
manufacturer’s instructions, and these data were
expressed relative to standard curves prepared for them.
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Co-immunoprecipitation (Co-IP)
Protein A + G agarose for IP was washed twice with lysis
buffer. Total protein (100 μg) from each sample was di-
luted in 500 μL lysis buffer. Approximately 1 μg of con-
ventional IgG, which was identical to the IgG used for
IP, was added with 25 μL fully resuspended protein A +
G agarose and gently mixed on a rocker at 4 °C for
30 min. Samples were then centrifuged at 1000 × g for
5 min at 4 °C, and the supernatant was collected for subse-
quent IP and removal of nonspecific antigens. Next, protein
solution was added with 2 μg of the corresponding primary
antibody, and the mixture was incubated on a rocker at 4 °C
for 1 h. After thorough binding between antigen and
primary antibody, 50 μL of fully resuspended protein A +
G agarose was added, and the reaction was gently mixed
on a rocker at 4 °C overnight. The mixture was then centri-
fuged at 1000 × g for 5 min at 4 °C, and the supernatant
was discarded. The beads were washed three times with
lysis buffer, and 75 μL 4× SDS sample buffer was added.
The sample was boiled at 100 °C for 5 min and then centri-
fuged at 1000 × g for 5 min at 4 °C. The supernatant was
collected and placed in a new Eppendorf tube. Each pre-
pared sample was used directly in western blot analysis.
Data analysis
All data are expressed as mean ± SEM. One-way ANOVA
for multiple comparisons and Student-Newman-Keuls
post hoc test were performed for TUNEL and FJB stain-
ing, immunofluorescence staining, immunoprecipitation
analysis, and western blot. p < 0.05 was considered statisti-
cally significant.
Results
ICH-induced increase in the expressions of PD-1 and
PD-L1 and the interaction between them in the brain
tissue around hematoma in rats
Expression of PD-1 protein in brain tissues from ICH
model rats significantly increased at 24 h after ICH on-
sets. Results of western blot analysis showed that PD-1
protein expression in post-ICH 24 h, post-ICH 48 h,
and post-ICH 72 h subgroups of ICH rats were signifi-
cantly higher than that in the sham group (Fig. 2a). In
addition, PD-L1 protein expression in post-ICH 24 h
and post-ICH 48 h subgroups of ICH rats also in-
creased. This enhanced expression of PD-L1 protein
decreased in the post-ICH 72 h subgroup, which had
similar PD-L1 protein expression levels as the control
group (Fig. 2a). No significant changes in PD-L2 pro-
tein expression were found in the different groups
(Fig. 2a). In addition, ICH also increased the interaction
between PD-1 and PD-L1 at post-ICH 12 h, post-ICH
24 h, and post-ICH 48 h (Fig. 1b, c). And the protein
levels of PD-1 and PD-L1 and the interaction between
them, as well as the phosphorylation of STAT1, collect-
ively peaked at 24 h after ICH. Therefore, we selected
the post-ICH 24 h subgroup to study the effect of PD-
1/PD-L1 on ICH-induced SBI.
Fig. 2 ICH increased the protein levels of PD-1/PD-Ls and the interaction between PD-1 and PD-L1. a Time course of the protein levels of PD-1,
PD-L1, and PD-L2 in the brain tissue around hematoma after ICH. Representative western blot bands of PD-1, PD-L1, and PD-L2 and quantitative
analysis of the relative protein level were shown. The mean value of sham group was normalized to 1.0. Data are expressed as mean ± SEM, n = 6.
Double asterisks indicate p < 0.01, triple asterisks indicate p < 0.001 vs. sham group. b, c Immunoprecipitation analysis of the interaction between
PD-1 and PD-L1 at indicated times after ICH. All values are means ± SEM, n = 6. triple asterisks indicate p < 0.001 vs. sham group, triple pound signs
indicate p < 0.001
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Effects of overexpression and knockdown of PD-1 and
PD-L1 on brain cell death and neuronal degeneration in
ICH rats
The experimental group of Fig. 3 is shown in Fig. 3a.
Western blot assay showed that the protein levels of PD-1
and PD-L1 were significantly increased by pDNA transfec-
tion and decreased by siRNA transfection (Fig. 3b, c).
TUNEL assay and FJB staining were used to assess the ef-
fects of PD-1/PD-L1 on brain cell death and neuronal de-
generation in the brain after ICH modeling (Fig. 3d–g).
The numbers of TUNEL- and FJB-positive cells in rat
brains 24 h after ICH modeling were significantly higher
than those in the sham group. However, overexpression of
both PD-1 and PD-L1 significantly inhibited ICH-induced
brain cell death and neuronal degeneration, while knock-
down of them exerted an opposite effect. In addition,
inflammation-associated molecules, including IL-1β and
TNF-α, were tested. As shown in Fig. 3h, i, IL-1β and
TNF-α were found to be significantly higher in the serum
of the ICH group than that in the sham group. Compared
with ICH group, the mean inflammatory cytokine con-
tents were lower in overexpression group and higher in
knockdown group. The results also showed that there
were no significant differences between the vector group
and PD-1 plasmid group or PD-L1 plasmid group, while
there were significant differences between the control
siRNA group and PD-1 siRNA group or PD-L1 siRNA
group, suggesting that PD-1 and PD-L1complement each
other in modulation of brain cell death and neuronal de-
generation in ICH rats.
Effects of PD-1 and PD-L1 on ICH-induced microglia
polarization and STAT1 phosphorylation in rats
We next observed the effects of PD-1 and PD-L1 over-
expression or knockdown on the microglia polarization
in ICH rat brain (Fig. 4). The experimental group of
Fig. 4 is shown in Fig. 4a. The results showed that ICH
induced microglia polarization to a pro-inflammatory
phenotype, as defined by CD16/CD11b-positive, and also
to an anti-inflammatory phenotype, as defined by
CD206/CD11b-positive (Fig. 4b–e). The results also
showed that ICH mainly selectively modulated microglia
polarizing to pro-inflammatory phenotype, which was
ameliorated by overexpression of PD-1 and PD-L1 and
aggravated by knockdown of PD-1 and PD-L1. To fur-
ther elucidate the role of PD-1 and PD-L1 in microglia
polarization, we co-stained brain sections of ICH + PD-1
overexpression + PD-L1 overexpression group for PD1,
CD16 and CD11b or PD1, CD206, and CD11b (Fig. 4f ).
The results demonstrated that almost all of the CD206/
CD11b-positive cells were co-labeled with high fluores-
cence intensity of PD1, while almost all of the CD16/
CD11b-positive cells showed almost undetectable fluor-
escence intensity of PD1.
In addition, we used western blot analysis to measure
the phosphorylation level of STAT1. Our results indicated
that the phosphorylation level of p-STAT1 after ICH mod-
eling was significantly higher than that in the sham group
and peaked at 24 h after ICH onsets (Fig. 4g). And the
phosphorylation level of STAT1 was decreased by overex-
pression of PD-1 and PD-L1 and further increased by
knockdown of PD-1 and PD-L1 (Fig. 4h).
Critical role of PD-1 and PD-L1 in microglia polarization in
cultured microglia under OxyHb treatment
We next observed the effects of PD-1 and PD-L1 over-
expression or knockdown on microglia polarization in
cultured microglia under OxyHb treatment (Fig. 5).
The experimental group of Fig. 5 is shown in Fig. 5a.
Firstly, the expression plasmid-mediated overexpression
of PD1 and PD-L1 as well as the efficiency of siRNA-
mediated knockdown in cultured microglia is verified
by immunofluorescence staining (Fig. 5b). In addition,
double-immunofluorescence analysis showed that OxyHb
treatment induced microglia polarization both to a pro-
inflammatory phenotype and an anti-inflammatory pheno-
type (Fig. 5c–f ). The results also showed that OxyHb
treatment mainly selectively modulated microglia polariz-
ing to pro-inflammatory phenotype, which was amelio-
rated by overexpression of PD-1 and PD-L1 and
aggravated by knockdown of PD-1 and PD-L1. To further
elucidate the role of PD-1 and PD-L1 in microglia
polarization, we co-stained brain sections of OxyHb + PD-
1 overexpression + PD-L1 overexpression group for PD1,
CD16 and CD11b or PD1, CD206, and CD11b (Fig. 5g).
The results demonstrated that almost all of the CD206/
CD11b-positive cells were co-labeled with high fluores-
cence intensity of PD1, while almost all of the CD16/
CD11b-positive cells showed almost undetectable fluores-
cence intensity of PD1.
In addition, as previously reported [29], the use of
single phenotypic markers (CD206 and CD16) is not
sufficient to identify microglia polarization. Inflammation-
associated molecules, including TNF-α, IL-1β, iNOS,
arginase1, IL-4, and IL-10, were tested to provide
more information on the biological state of microglia
after ICH and the roles of PD-1 and PD-L2 in the
process (Fig. 6). The results showed that the mean
protein levels of pro-inflammation molecules, including
TNF-α, IL-1β, and iNOS, in cultured microglia were sig-
nificantly increased by OxyHb treatment. However,
among the anti-inflammation molecules, including argi-
nase1, IL-4 and IL-10, only the protein level of arginase1
was increased after OxyHb treatment. These results sug-
gested that OxyHb induced microglia polarization to a
pro-inflammation phenotype. In addition, a significant de-
crease in the mean protein levels of TNF-α, IL-1β, and
iNOS and a significant increase in the mean protein levels
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Fig. 3 Effects of PD-1/PD-L1 overexpression and knockdown on brain cell death and neuronal degeneration after ICH. a ICH rats accepted intra-
cerebroventricular injection of pDNA or siRNAs as indicated. b Western blot analysis of the efficiency of PD-1 and PD-L1 overexpression or knockdown
in brain of ICH rats. Quantification of relative protein levels of PD-1 and PD-L1 was shown in c. c Data are expressed as mean ± SEM, n = 6.
Triple asterisks indicate p < 0.001 vs. ICH + vector group; triple pound signs indicate p < 0.001 vs. ICH + control siRNA group. d Terminal deoxynu-
cleotidyl transferase dUTP nick end labeling (TUNEL) staining. Sections were labeled by TUNEL (green) to detect apoptotic brain cells and coun-
terstained with DAPI (blue) to detect nuclei. Arrows point to TUNEL-positive cells. Scale bar = 64 μm. e Percentage of TUNEL-positive cells. Data are
expressed as mean ± SEM, n = 6. Triple asterisks indicate p < 0.001 vs. sham group; double pound signs indicate p < 0.01 vs. ICH + vector group; amper-
sand indicates p < 0.05, double ampersands indicate p < 0.01 vs. ICH + control siRNA group. f Fluoro-jade B (FJB) staining. Arrows point to FJB-positive
cells. Scale bar = 64 μm. The number of FJB-positive brain cells was calculated. g Data are expressed as mean ± SEM, n = 6. Triple asterisks
indicate p < 0.001 vs. sham group; double pound signs indicate p < 0.01 vs. ICH + vector group; double ampersands indicate p < 0.01, triple ampersands
indicate p < 0.001 vs. ICH + control siRNA group. h, i ELISA assay of the contents of IL-1β and TNF-α in the serum. The mean values of the sham group
were normalized to 1.0. Data are expressed as mean ± SEM, n = 6. Single asterisk indicates p < 0.05 vs. sham group; Single pound sign indicates p < 0.05
vs. ICH + vector group; Single ampersand indicates p < 0.05, double ampersands indicate p < 0.01 vs. ICH + control siRNA group
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of arginase 1, IL-4, and IL-10 were observed in microglia
with PD-1 and PD-L1 overexpression, while opposite
trends were shown in microglia with PD-1 and PD-L1
knockdown, suggesting that PD-1 and PD-L1 selectively
inhibited OxyHb-induced pro-inflammation polarization
of microglia.
In addition, the mean protein levels of pro-
inflammatory markers, including TNF-α, IL-1β, and
iNOS, in cultured microglia were significantly increased
by OxyHb treatment (Fig. 6). However, among the anti-
inflammatory markers, including arginase 1, IL-4, and
IL-10, only the protein level of arginase1 was increased
Fig. 4 Effects of PD-1/PD-L1 overexpression and knockdown on ICH-induced microglia polarization and STAT1 phosphorylation. a ICH rats accepted
intracerebroventricular injection of pDNA or siRNAs as indicated. Sections were stained for CD16/CD11b (pro-inflammatory microglia marker)
or CD206/CD11b (anti-inflammatory microglia marker). Percentage of CD16-positive cells or CD206-positive cells was shown in b and d and
representative images were shown in c and e. Scale bar = 64 μm. In b and d, data are expressed as mean ± SEM, n = 6. Triple asterisks indicate
p < 0.001 vs. sham group; single pound sign indicates p < 0.05, double pound signs indicate p < 0.01 vs. ICH + vector group; single ampersand
indicates p < 0.05, double ampersands indicate p < 0.01 vs. ICH + control siRNA group. f Sections of ICH + PD-1 overexpression + PD-L1 overexpression
group were stained for PD1/CD16/CD206. White arrows point to CD206-positive cells with high fluorescence intensity of PD-1, and purple arrows point
to CD16-positive cells with low fluorescence intensity of PD-1. Scale bar = 64 μm. g Western blot analysis and quantification of the phosphorylation
level of STAT1. The mean values of the protein levels in the sham group were normalized to 1.0. Data are expressed as mean ± SEM, n = 6.
Double asterisks indicate p < 0.01, triple asterisks indicate p < 0.001 vs. sham group; double pound signs indicate p < 0.01, single ampersand indi-
cates p < 0.05. h Western blot analysis and quantification of the phosphorylation level of STAT1. The mean values of the protein levels in the
ICH group were normalized to 1.0. Data are expressed as mean ± SEM, n = 6. Double asterisks indicate p < 0.01 vs. ICH + vector group; single
pound sign indicates p < 0.05, double pound signs indicate p < 0.01 vs. ICH + control siRNA group
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Fig. 5 Effects of PD-1/PD-L1 overexpression and knockdown on the polarization of OxyHb-treated microglia. a Cultured microglia accepted trans-
fection of pDNA or siRNAs as indicated. b The efficiency of pDNA and siRNA in cultured microglia was verified by immunofluorescence staining.
Scale bar = 64 μm. Cultured microglia was stained for CD16/CD11b (pro-inflammatory microglia marker) or CD206/CD11b (anti-inflammatory
microglia marker). Percentage of CD16-positive cells or CD206-positive cells was shown in c and e and representative images were shown in d
and f. Scale bar = 64 μm. In c and e, data are expressed as mean ± SEM, n = 6. Single asterisk indicates p < 0.05, triple asterisks indicate p < 0.001 vs.
sham group; single pound sign indicates p < 0.05, double pound signs indicate p < 0.01 vs. ICH + vector group; single ampersand indicates p < 0.05,
double ampersands indicate p < 0.01 vs. ICH + control siRNA group. g Microglia of ICH + PD-1 overexpression + PD-L1 overexpression group was
stained for PD1/CD16/CD206. White arrows point to CD206-positive cells with high fluorescence intensity of PD-1, and purple arrows point to
CD16-positive cells with low fluorescence intensity of PD-1. Scale bar = 64 μm
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after OxyHb treatment. These results suggested that
OxyHb induced microglia activation and mainly pro-
moted microglia polarization to pro-inflammatory
phenotype. A significant decrease in the mean protein
levels of pro-inflammatory markers and a significant in-
crease in the mean protein levels of anti-inflammatory
markers were observed in microglia with PD-1 and PD-
L1 overexpression, while opposite trends were shown in
microglia with PD-1 and PD-L1 knockdown, suggesting
that PD-1 and PD-L1 selectively inhibited OxyHb-
induced pro-inflammatory polarization of microglia.
Discussion
In this study, we established a rat model of ICH to deter-
mine whether PD-1/PD-Ls play a role in SBI and to elu-
cidate the potential mechanisms. Our findings showed
that PD-1/PD-L1 protein expression in brain tissue sig-
nificantly increased after ICH. In addition, the propor-
tion of STAT1 phosphorylation increased after ICH.
These changes were more significant ~24 h after ICH.
Overexpression of PD1 and PD-L1 inhibited STAT1
phosphorylation, which was an important factor for
transforming microglia to the pro-inflammatory subtype.
Thus, these results suggested that enhancing the expres-
sions of PD-1 and PD-L1 may induce a selective modu-
lation of microglia polarization to anti-inflammatory
phenotype via STAT1 for ICH treatment (Fig. 7). This
finding has not been reported in previous studies.
In a study of autoimmune encephalomyelitis, Carter et
al. [30] showed that PD-1/PD-L1 but not PD-L2 are
involved in T cell activation. In this study, we demon-
strated that PD-1 and PD-L1 but not PD-L2 protein ex-
pression significantly reduced early brain injury (Fig. 2).
Thus, we suggest that the PD-1/PD-L1 signaling pathway
plays an important role in regulating the inflammatory re-
sponse in nervous tissue. In the ICH rat model, PD-1 and
PD-L1 protein expression and their binding to each other
were elevated 24 h after ICH modeling, further indicating
Fig. 6 Changes in the expression of pro-inflammatory- and anti-inflammatory-like polarization markers in microglia under indicated treatment. a
The immunoblots show TNF-α, IL-1β, iNOS, arginase1, IL-4, and IL-10 produced by microglia under indicated treatment. b The quantitative analyses of
TNF-α, IL-1β, iNOS, arginase1, IL-4, and IL-10 in the immunoblots in a. Date =mean ± SEM, n = 6. Single asterisk indicates p < 0.05 vs. control group;
single pound sign indicates p < 0.05 vs. ICH + vector group; single ampersand indicates p < 0.05, double ampersands indicate p < 0.01 vs. ICH + control
siRNA group
Fig. 7 Possible mechanism of PD-1/PD-L1 in secondary brain injury
after ICH modeling. After ICH, PD-1/PD-L1 protein expression in the
brain tissue significantly increased. In addition, the proportion of
STAT1 phosphorylation increased. Moreover, upregulation of PD-1/
PD-L1 expression by overexpression suppressed the phosphorylation
of p-STAT1, pro-inflammatory polarization of microglia, and subsequent
SBI under ICH condition, while PD-1/PD-L1 knockdown induced an
opposite effect
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that PD-1/PD-L1 are involved in ICH-induced SBI. The
severity of brain injury was alleviated increased protein
expression of both PD-1 and PD-L1. In contrast, reduced
PD-1 and PD-L1 protein expression increased the severity
of brain injury, indicating a causal relationship between
PD-1/PD-L1 and brain injury (Fig. 3).
Microglia/macrophages effectively regulate restoration
and regeneration of the CNS. However, these molecules
can act as double-edged swords, resulting in both de-
struction and restoration [31]. Further studies have dem-
onstrated that activation of microglia/macrophages can
convert the cells into two opposite phenotypes: pro-
inflammatory microglia that release destructive inflam-
matory cytokines and anti-inflammatory microglia that
release cytokines for protection and restoration [25, 32].
In addition, multiple members of the STAT family (i.e.,
STAT1, STAT3, and STAT6) are involved in morpho-
logical typing of microglia/macrophages. For example,
STAT1 promotes transformation of microglia into pro-
inflammatory microglia [19, 33], and STAT6 stimulates
transformation of microglia into anti-inflammatory
microglia [34]. Moreover, STAT1 and STAT6 have a mu-
tually inhibitory relationship [35]. In this study, the ratio
of p-STAT1/STAT1 was significantly increased following
ICH (Fig. 4g), while ICH did not affect the level of p-
STAT6/STAT6 significantly (data not shown). Among
the different ICH rat model groups, the proportion of
phosphorylated STAT1 was maximal 24 h after ICH.
PD-1 reduced phosphorylation of STAT1, which was
consistent with the result of a previous study [36]. The
possible mechanism may be due to PD-1 blocking the
PI3K-Akt pathway, which inhibits promotion of phos-
phorylation of STAT1 [18]. In a mouse model of spinal
cord injury, inhibition of PD-1 promotes transformation
of microglia/macrophages into pro-inflammatory micro-
glia [36]. These findings support our hypothesis that
PD-1/PD-L1 is involved in inhibiting pro-inflammatory
polarization of microglia under conditions of ICH [36].
There are several limitations of this study. In vitro ex-
periment showed OxyHb maybe an incentive for the in-
crease in the expressions of PD-1 and PD-L1. However,
due to lacking studies of other contents of hematoma,
this study cannot draw the mechanism underlying ICH-
induced increase in the expressions of PD-1 and PD-L1.
In addition, whether ICH-induced increase in the ex-
pressions lead to ICH-induced increase in the inter-
action between PD-1 and PD-L1 is also not answered in
this study. It also reported that the PD-L1-mediated in-
flammatory response expanded the infarct size in experi-
mental stroke model [37]. The possible mechanism may
involve binding between PD-L1 and CTLA-4. CTLA-4
inhibits Akt phosphorylation through activation of pro-
tein phosphatase 2 (PP2A) [17, 38]. And a study has
shown that PD-1 can inhibit PD-L1 protein expression
by promoting transcription of MicroRNA 513 [39] to
negatively regulate PD-L1 and play a neuroprotective ef-
fect in nervous tissue. The effect of CTLA-4 and Micro-
RNA 513 on microglia polarization in ICH condition
deserves further study.
Conclusions
Microglia polarization is part of the basic machinery of
brain injury. PD-1/PD-L1, a typical member of immuno-
globulin superfamily, plays a critical role in neuroim-
mune cell functions. On the other hand, much attention
has been also paid to the role of STATs in microglia
polarization. In this study, using in vivo and in vitro
models of relevance to ICH, we found a critical role of
PD-1/PD-L1 through STAT1 in the polarization of
microglia. These findings suggest PD-1/PD-L1 as prom-
ising pharmacological targets for the treatment of
hemorrhagic brain injury.
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